E2F4 signature can predict progression of bladder cancer

Investigators harnessed genomic data to discover that the previously identified E2F4 signature in breast cancer can be utilized to predict prognosis and response to therapy in bladder cancer. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail